The role of the ICOS/B7RP‐1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis
The role of the ICOS/B7RP‐1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis
复制标题
DOI:
10.1002/eji.200636138
复制
发表时间:
2006-11
影响因子:
5.4
通讯作者:
Y. Usui;H. Akiba;M. Takeuchi;T. Kezuka;A. Takeuchi;T. Hattori;Y. Okunuki;Tomohide Yamazaki;H. Yagita;M. Usui;K. Okumura
中科院分区:
文献类型:
--
作者:
Y. Usui;H. Akiba;M. Takeuchi;T. Kezuka;A. Takeuchi;T. Hattori;Y. Okunuki;Tomohide Yamazaki;H. Yagita;M. Usui;K. Okumura
ICOS/B7RP‐1 is a new member of the CD28/B7 family of costimulatory molecules and plays differential roles in autoimmune diseases. In this study, we examined the role of ICOS/B7RP‐1 pathway in the pathogenesis of mouse experimental autoimmune uveoretinitis (EAU), an animal model of human autoimmune uveitis. ICOS expression was found on infiltrating CD4+ T cells in the region of the retina in EAU‐induced mice. The anti‐B7RP‐1 monoclonal antibody (mAb)‐treated or ICOS‐deficient mice showed a substantial reduction of disease scores. Blockade of ICOS/B7RP‐1 interaction during the effector phase ameliorated the disease, whereas its blockade during the induction phase exhibited no significant effect. Moreover, administration of anti‐B7RP‐1 mAb effectively ameliorated the disease induced by adoptive transfer of pathogenic T cells. The anti‐B7RP‐1 mAb treatment inhibited the expansion and/or effector function of pathogenic T cells, given that proliferative response and IFN‐γ production by lymph node cells were reduced upon restimulation with the antigen peptide in vitro. These results suggest that the ICOS/B7RP‐1 interaction plays a critical role in the pathogenesis of uveitis. We also indicated that ICOS‐mediated costimulation plays differential roles in EAU and experimental autoimmune encephalomyelitis, which is also a Th1 disease induced in the same manner as EAU.